Singapore markets close in 6 hours 38 minutes
Straits Times Index
3,307.52 +4.33 (+0.13%) Nikkei
38,674.65 +438.58 (+1.15%) Hang Seng
18,530.62 -47.68 (-0.26%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,721.95 -480.77 (-0.75%) CMC Crypto 200
1,373.63 +61.01 (+4.65%)
NGM Biopharmaceuticals Inc (0IK.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 08:04AM CEST
| Previous close | 1.4500 |
| Open | 1.4500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.4500 - 1.4500 |
| 52-week range | 0.5700 - 4.0000 |
| Volume | |
| Avg. volume | 73 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 10.81% and 91.75%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Why NGM Biopharmaceuticals (NGM) Might Surprise This Earnings Season
NGM Biopharmaceuticals (NGM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Simply Wall St.
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75% over the previous year
Key Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock price might be...
© 2024 Yahoo. All rights reserved.